Affiliation: University of Copenhagen
- Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patientsM Skov
Department of Pediatrics, National University Hospital, CF centre 5003, Blegdamsvej 9, Copenhagen 2100, Denmark
J Cyst Fibros 3:173-8. 2004..We examined whether this characteristic immune response was under the influence of GM and KM allotypes, which are genetic markers (antigenic determinants) on gamma- and kappa-light chains, respectively...
- Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonideM Skov
Cystic Fibrosis Centre, National University Hospital, Rigshospitalet, Copenhagen, Denmark
Eur Respir J 20:127-33. 2002..In patients treated with this combination, screening for adrenal insufficiency at regular intervals is suggested...
- Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopyMarianne Skov
Department of Respiratory Medicine, The CF Clinic, The Children s Hospital at Westmead, Rigshopitalet, Copenhagen, Denmark
Respir Med 99:887-93. 2005..In the Australian population there is a high frequency of atopy and the climate is relatively humid...
- [Adrenal cortex insufficiency after combination therapy with itraconazole and budesonide]Marianne Skov
H S Rigshospitalet, Juliane Marie Centret, CF Centret og Afdelingen for Vaekst og Reproduktion, og Abdominalcentret, Hepatologisk Afdeling, København Ø
Ugeskr Laeger 165:2198-201. 2003
- Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosisM Skov
CF Center, Department of Pediatrics, National University Hospital, Rigshospitalet, Copenhagen, Denmark
Allergy 57:723-8. 2002..Despite serious side effects long-term treatment with corticosteroids is often required. Itraconazole has been reported to be a useful steroid-sparing agent...
- Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patientK M Main
Department of Growth and Reproduction, The National University Hospital, Rigshospitalet, Copenhagen, Denmark
Acta Paediatr 91:1008-11. 2002..Discontinuation of both drugs led to an improvement in clinical symptoms and recovery of the pituitary-adrenal axis after 3 mo...
- Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?K Aanaes
Department of Otorhinolaryngology, Rigshospitalet, University of Copenhagen, Denmark
Rhinology 51:222-30. 2013....
- Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient populationT Qvist
Copenhagen CF centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Transplant Proc 45:342-5. 2013..The study supports the contention that CF patients with prior or active NTM can undergo lung transplantation although postoperative complications can be expected...
- Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contactC R Hansen
Department of Pediatrics, Copenhagen CF centre, University Hospital Rigshospitalet, Copenhagen, Denmark Electronic address
J Cyst Fibros 12:609-15. 2013..Achromobacter species leads to chronic infection in an increasing number of CF patients. We report 2 cases of Achromobacter ruhlandii cross-infection between patients after well-described indirect contact...
- Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus ConferenceDavid A Stevens
Department of Medicine, Santa Clara Valley Medical Center, Stanford University Medical School, San Jose, California 95128 2699, USA
Clin Infect Dis 37:S225-64. 2003..Diagnostic criteria that could provide a framework for monitoring were adopted, and helpful imaging features were identified. New possibilities in therapy produced plans for managing diverse clinical presentations...
- Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control studyTacjana Pressler
Copenhagen Cystic Fibrosis Center, Department of Paediatrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen corrected Denmark
J Cyst Fibros 5:9-15. 2006..9, 7.7 and 7.4, respectively (p<0.005), and growth of mucoid P. aeruginosa strains with OR of 7.4, p=0.006). Occurrence of Aspergillus was also a risk factor for developing chronic P. aeruginosa infection with the OR of 4.7 (p=0.008)...